Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Intranasal Dexmedetomidine in Children
NCT02836431Phase 1Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dexmedetomidine (3 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoints: Maximum blood concentration level of DEX at 2 hours, Time to maximum concentration at 2 hours and 2 more. Started Jan 2016; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT02836431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02836431.